Estimates Revisions Immutep Limited Nasdaq
Stocks
IMMP
US45257L1089
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3751 USD | -4.36% |
|
-1.24% | -86.88% |
| 07-15 | Immutep highlights encouraging survival data and key clinical milestones | FI |
| 07-14 | Immutep Granted New US Patent for Cancer Treatment Methods | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- IMM Stock
- IMMP Stock
- Consensus Immutep Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
